Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer

Yan Liu,1,2,* Meng Gao,3,* Juan An,2,* Xin Wang,4 Yan Jia,4 Junfeng Xu,4 Jihai Zhu,5 Jiantao Cui,1 Wenmei Li,1 Rui Xing,1 Li Song,6 Kejia Liu,6 Yuqi He,4 Jianqiu Sheng,4 Shengmei Qi,3 Yuanming Pan,1,4 Youyong Lu1 1Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational R...

Full description

Bibliographic Details
Main Authors: Liu Y, Gao M, An J, Wang X, Jia Y, Xu J, Zhu J, Cui J, Li W, Xing R, Song L, Liu K, He Y, Sheng J, Qi S, Pan Y, Lu Y
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/dysregulation-of-mir-30a-3pgastrin-enhances-tumor-growth-and-invasion--peer-reviewed-article-OTT
id doaj-19b886f2bb4846f79806d5b6e686320f
record_format Article
spelling doaj-19b886f2bb4846f79806d5b6e686320f2020-11-25T03:42:42ZengDove Medical PressOncoTargets and Therapy1178-69302020-08-01Volume 138475849356580Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric CancerLiu YGao MAn JWang XJia YXu JZhu JCui JLi WXing RSong LLiu KHe YSheng JQi SPan YLu YYan Liu,1,2,* Meng Gao,3,* Juan An,2,* Xin Wang,4 Yan Jia,4 Junfeng Xu,4 Jihai Zhu,5 Jiantao Cui,1 Wenmei Li,1 Rui Xing,1 Li Song,6 Kejia Liu,6 Yuqi He,4 Jianqiu Sheng,4 Shengmei Qi,3 Yuanming Pan,1,4 Youyong Lu1 1Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing, Haidian District 100142, People’s Republic of China; 2Department of Basic Medical Sciences, Medical College of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 3OnkoRx Ltd. Beijing, Beijing, Haidian District 100085, People’s Republic of China; 4Department of Gastroenterology, The 7th Medical Center of Chinese PLA General Hospital, Beijing, Dongcheng District 100700, People’s Republic of China; 5Department of Cardiothoracic Surgery, The Affiliated Hospital of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 6Yidu Cloud (Beijing) Technology Co., Ltd. 8F, Health Work, Beijing, Haidian District 100083, People’s Republic of China*These authors contributed equally to this workCorrespondence: Youyong Lu, MD, Ph.D.Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing 100142, People’s Republic of ChinaTel +86-10-88196765Fax +86-10-88122437Email youyonglu@hsc.pku.edu.cnBackground: Gastrin (GAST) is a well-known hormone regulating gastric biofunctions in the secretion of acid and maintaining its structural integrity. Furthermore, the dysregulation of GAST is also involved in the development of various forms of cancer. However, there are some limitations for illustrating the cellular regulation of GAST and its regulatory mechanisms in gastric malignant transformation and the potential epigenetic regulators systematically.Methods: We explored the role of GAST expression in gastric cancer (GC) and normal tissues with the clinical features and investigated the potential relationship between GAST and STAT3/MMP11 pathway by gain or loss of function analyses. Besides, based on our microRNA/mRNA expression profiles, miR-30a-3p was the potential epigenetic regulator and additional experiments were performed to identify the hypothesis.Results: Elevated GAST expression was frequently detected in GC and was associated with worse outcomes (p< 0.001). And we firstly demonstrated that GAST was negatively regulated by miR-30a-3p. Moreover, GAST induced GC cell proliferation, migration and invasion mediating STAT3/MMP11 pathway in this study.Conclusion: MiR-30a-3p was the promising suppressor gene through negatively regulating the expression of GAST, and dysregulation of GAST was a prognostic signature associated cell proliferation and metastasis through STAT3/MMP11 pathway in GC.Keywords: gastrin, proliferation, invasion, miR-30a-3p, STAT3/MMP11 pathway, gastric cancerhttps://www.dovepress.com/dysregulation-of-mir-30a-3pgastrin-enhances-tumor-growth-and-invasion--peer-reviewed-article-OTTgastrinproliferationinvasionmir-30a-3pstat3/mmp11 pathwaygastric cancer
collection DOAJ
language English
format Article
sources DOAJ
author Liu Y
Gao M
An J
Wang X
Jia Y
Xu J
Zhu J
Cui J
Li W
Xing R
Song L
Liu K
He Y
Sheng J
Qi S
Pan Y
Lu Y
spellingShingle Liu Y
Gao M
An J
Wang X
Jia Y
Xu J
Zhu J
Cui J
Li W
Xing R
Song L
Liu K
He Y
Sheng J
Qi S
Pan Y
Lu Y
Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer
OncoTargets and Therapy
gastrin
proliferation
invasion
mir-30a-3p
stat3/mmp11 pathway
gastric cancer
author_facet Liu Y
Gao M
An J
Wang X
Jia Y
Xu J
Zhu J
Cui J
Li W
Xing R
Song L
Liu K
He Y
Sheng J
Qi S
Pan Y
Lu Y
author_sort Liu Y
title Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer
title_short Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer
title_full Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer
title_fullStr Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer
title_full_unstemmed Dysregulation of MiR-30a-3p/Gastrin Enhances Tumor Growth and Invasion throughSTAT3/MMP11 Pathway in Gastric Cancer
title_sort dysregulation of mir-30a-3p/gastrin enhances tumor growth and invasion throughstat3/mmp11 pathway in gastric cancer
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2020-08-01
description Yan Liu,1,2,* Meng Gao,3,* Juan An,2,* Xin Wang,4 Yan Jia,4 Junfeng Xu,4 Jihai Zhu,5 Jiantao Cui,1 Wenmei Li,1 Rui Xing,1 Li Song,6 Kejia Liu,6 Yuqi He,4 Jianqiu Sheng,4 Shengmei Qi,3 Yuanming Pan,1,4 Youyong Lu1 1Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing, Haidian District 100142, People’s Republic of China; 2Department of Basic Medical Sciences, Medical College of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 3OnkoRx Ltd. Beijing, Beijing, Haidian District 100085, People’s Republic of China; 4Department of Gastroenterology, The 7th Medical Center of Chinese PLA General Hospital, Beijing, Dongcheng District 100700, People’s Republic of China; 5Department of Cardiothoracic Surgery, The Affiliated Hospital of Qinghai University, Xining City, Qinghai 810001, People’s Republic of China; 6Yidu Cloud (Beijing) Technology Co., Ltd. 8F, Health Work, Beijing, Haidian District 100083, People’s Republic of China*These authors contributed equally to this workCorrespondence: Youyong Lu, MD, Ph.D.Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing Cancer Hospital/Institute, School of Oncology, Peking University, Beijing 100142, People’s Republic of ChinaTel +86-10-88196765Fax +86-10-88122437Email youyonglu@hsc.pku.edu.cnBackground: Gastrin (GAST) is a well-known hormone regulating gastric biofunctions in the secretion of acid and maintaining its structural integrity. Furthermore, the dysregulation of GAST is also involved in the development of various forms of cancer. However, there are some limitations for illustrating the cellular regulation of GAST and its regulatory mechanisms in gastric malignant transformation and the potential epigenetic regulators systematically.Methods: We explored the role of GAST expression in gastric cancer (GC) and normal tissues with the clinical features and investigated the potential relationship between GAST and STAT3/MMP11 pathway by gain or loss of function analyses. Besides, based on our microRNA/mRNA expression profiles, miR-30a-3p was the potential epigenetic regulator and additional experiments were performed to identify the hypothesis.Results: Elevated GAST expression was frequently detected in GC and was associated with worse outcomes (p< 0.001). And we firstly demonstrated that GAST was negatively regulated by miR-30a-3p. Moreover, GAST induced GC cell proliferation, migration and invasion mediating STAT3/MMP11 pathway in this study.Conclusion: MiR-30a-3p was the promising suppressor gene through negatively regulating the expression of GAST, and dysregulation of GAST was a prognostic signature associated cell proliferation and metastasis through STAT3/MMP11 pathway in GC.Keywords: gastrin, proliferation, invasion, miR-30a-3p, STAT3/MMP11 pathway, gastric cancer
topic gastrin
proliferation
invasion
mir-30a-3p
stat3/mmp11 pathway
gastric cancer
url https://www.dovepress.com/dysregulation-of-mir-30a-3pgastrin-enhances-tumor-growth-and-invasion--peer-reviewed-article-OTT
work_keys_str_mv AT liuy dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT gaom dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT anj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT wangx dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT jiay dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT xuj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT zhuj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT cuij dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT liw dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT xingr dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT songl dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT liuk dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT hey dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT shengj dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT qis dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT pany dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
AT luy dysregulationofmir30a3pgastrinenhancestumorgrowthandinvasionthroughstat3mmp11pathwayingastriccancer
_version_ 1724524109146095616